AeroLeads people directory · profile
Christopher Tapper Email & Phone Number
Senior Investment Associate
at
Cambridge Innovation Capital
1 work email found
@lek.com
LinkedIn matched
✓ Verified Jun 2026
3 data sources
Profile completeness 86%
Current company
Role
Senior Investment Associate
Location
Greater London, England, United Kingdom
Company size
Who is Christopher Tapper? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Christopher Tapper is listed as Senior Investment Associate at Cambridge Innovation Capital, a company with 35 employees, based in Greater London, England, United Kingdom. AeroLeads shows a work email signal at lek.com and a matched LinkedIn profile for Christopher Tapper.
Christopher Tapper previously worked as Board Observer at Carrick Therapeutics and Board Observer at Epitopea.
Company email context
Email format at Cambridge Innovation Capital
This section adds company-level context without repeating Christopher Tapper's masked contact details.
{first_initial}{last}@lek.com
76% confidence
AeroLeads found 1 current-domain work email signal for Christopher Tapper. Compare company email patterns before reaching out.
Profile bio
About Christopher Tapper
Christopher Tapper is a Senior Investment Associate at Cambridge Innovation Capital. He possess expertise in research, leadership, microsoft office, teamwork, public speaking and 8 more skills.
Listed skills include Research, Leadership, Microsoft Office, Teamwork, and 9 others.
Current workplace
Christopher Tapper's current company
Company context helps verify the profile and gives searchers a useful next step.
Cambridge Innovation Capital
14 roles
Christopher Tapper work experience
A career timeline built from the work history available for this profile.
Board Observer
CurrentCarrick Therapeutics is a clinical-stage biopharmaceutical company focused on building the future of oncological therapy to improve patient outcomes. Our extensive experience in developing innovative therapies allows us to deliver a novel best-in-class and first-in-class portfolio.
Mar 2023 - Present
Board Observer
CurrentExploiting a new class of tumour specific antigens for cancer therapy
Mar 2022 - Present
Senior Investment Associate
Current
Mar 2022 - Present
Investment Associate
Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem.Since our inception in 2013, we have raised over £500 million to.
Aug 2020 - Mar 2022
Board Observer
CurrentMicrobiotica identifies gut bacteria linked to phenotype with unprecedented precision in order to discover and develop live bacterial therapeutics and biomarkers.Initially built out of 10 years investment in the Wellcome Sanger Institute, Microbiotica has unrivalled capabilities in microbiome analysis linked to patient phenotype. It is the global leader in.
Sep 2020 - Present
Board Observer
CurrentExvastat is an innovative, clinical-stage pharmaceutical company founded in 2016, led by a small experienced management team with nearly 50 years combined pharmaceutical experience. The company is developing a treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications.
Aug 2020 - Present
Board Observer
Mosaic Therapeutics is an oncology therapeutics company using advanced computational methods and next-generation cancer models to discover and develop novel targeted therapies. The company’s main mission is to tackle cancers with substantial unmet need by reinventing the traditional approach to target and drug discovery.Born out of pioneering research at.
Oct 2022 - Jul 2024
External Innovations Manager
Apr 2019 - Aug 2020
Strategy Manager
Sep 2017 - Apr 2019
Life Sciences Senior Associate Consultant
Aug 2017 - Sep 2017
Life Sciences Associate Consultant
Sep 2016 - Aug 2017
Life Sciences Associate
Sep 2014 - Sep 2016
Research Assistant
Centre For Public Health, Northern Ireland
Position allocated through Queen's University Belfast. Primarily involved in pharmaco-epidemiological research, specifically concerning Multiple Myeloma and the use of 'statins', but also participated in the review and support of PhD driven research and publication development.My contribution during the internship was recognised with an award for the best.
Jun 2013 - Dec 2013
FAQ
Frequently asked questions about Christopher Tapper
Quick answers generated from the profile data available on this page.
What company does Christopher Tapper work for?
Christopher Tapper works for Cambridge Innovation Capital.
What is Christopher Tapper's role at Cambridge Innovation Capital?
Christopher Tapper is listed as Senior Investment Associate at Cambridge Innovation Capital.
What is Christopher Tapper's email address?
AeroLeads has found 1 work email signal at @lek.com for Christopher Tapper at Cambridge Innovation Capital.
Where is Christopher Tapper based?
Christopher Tapper is based in Greater London, England, United Kingdom while working with Cambridge Innovation Capital.
What companies has Christopher Tapper worked for?
Christopher Tapper has worked for Cambridge Innovation Capital, Carrick Therapeutics, Epitopea, Microbiotica, and Exvastat.
How can I contact Christopher Tapper?
You can use AeroLeads to view verified contact signals for Christopher Tapper at Cambridge Innovation Capital, including work email, phone, and LinkedIn data when available.
What skills is Christopher Tapper known for?
Christopher Tapper is listed with skills including Research, Leadership, Microsoft Office, Teamwork, Public Speaking, Powerpoint, Microsoft Word, and Social Media.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial